• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children

tetano

Editor, Senior Moderator
J Infect Dis


. 2020 Oct 22;jiaa665.
doi: 10.1093/infdis/jiaa665. Online ahead of print.
Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children


Michael Hinojosa[SUP] 1 2 [/SUP], Samuel S Shepard[SUP] 1 [/SUP], Jessie R Chung[SUP] 1 [/SUP], Jennifer P King[SUP] 3 [/SUP], Huong Q McLean[SUP] 3 [/SUP], Brendan Flannery[SUP] 1 [/SUP], Edward A Belongia[SUP] 3 [/SUP], Min Z Levine[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Pre-existing antibodies to influenza, shaped by early infection and subsequent exposures, may impact responses to influenza vaccination.
Methods: We enrolled 72 children (7-17 years) in 2015-16, all received inactivated influenza vaccines. Forty-one were also vaccinated in 2014-15 with 12 became infected with A(H3N2) in 2014-15. Thirty-one children did not have documented influenza exposures in the prior 5 seasons. Sera were collected pre- and post-vaccination in both seasons. We constructed antibody landscapes using hemagglutination inhibition antibody titers against 16 A(H3N2) viruses representative of major antigenic clusters that circulated between 1968 and 2015.
Results: The breadth of the antibody landscapes increased with age. Vaccine-induced antibody responses correlated with boosting of titers to previously encountered antigens. Post-vaccination titers were highest against vaccine antigens rather than the historic A(H3N2) viruses previously encountered. Pre-vaccination titers to the vaccine were the strongest predictors of post-vaccination titers. Responses to vaccine antigens did not differ by likely priming virus. Influenza A(H3N2) infected children in 2014-15 had narrower antibody landscapes than those uninfected, but prior season infection status had little effect on antibody landscapes following 2015-16 vaccination.
Conclusions: A(H3N2) antibody landscapes in children were largely determined by age-related immune priming, rather than recent vaccination or infection.

Keywords: antibody landscape; birth cohorts; immune priming; infection; influenza vaccination
 
Back
Top Bottom